News
3d
Stockhead on MSNBiocurious: Lumos shines a light on the post-pandemic rapid diagnosis sectorLumos Diagnostics is striving to become the leader in simple point-of-care tests to distinguish between viral and bacterial ...
AT&T has previously outlined its fiber ambitions. In December, Stankey said the company plans to reach more than 50 million ...
AI-powered platform ensures the right people and AI agents have the right access for the right time — reducing security risks, unlocking productivity, and driving profitability Lumos' new ...
Many Lumos customers will soon become T-Mobile fiber clients in a joint venture with EQT, a global investment organization, according to an announcement on Tuesday. The venture will expand T ...
2d
Stockhead on MSNASX Quarterly Health Wrap: Control Bionics reports strong US revenue, LTR Pharma makes progress with FDAASX quarterly season is upon us again, with listed companies opening a window to their performance and key activities over ...
Don't miss out on the headlines from Stockhead. Followed categories will be added to My News. Lumos is commercialising its FDA-approved Febridx test to distinguish between viral and bacterial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results